Therapies for Children With Autism Spectrum Disorders

Evidence Table. Therapies for children with ASD
Study
Inclusion/Exclusion Baseline
Description Intervention
Criteria/Population Measures Outcomes
Author:
Intervention:
Inclusion criteria: Communication/ Sensory:
Ludlow et al., Colored overlays; partici- • Attend a school in which language: Words read per
2006
pants selected the best a formal diagnosis of BPVS score, mean minute, mean:
Country: color and side (matt or autism is necessary ± SD:
G1a: NR*
UK
gloss) for clarity over text Exclusion criteria: G1: 64.32 ± 10.91 G1b: NR*
Practice
setting:
Frequency/duration:
Single session
• See inclusion criteria
Age, mean/yrs (range):
Sensory:
G1a/G1b: P <
City University Color 0.004
Academic Assessments:
G1: 11.10 ± 2.23 (8.3,15.1) Test score, mean ± Educational/
Intervention BPVS, City University Mental age:
SD:
cognitive/
setting:
NR
Color Vision Test (max =
16), Ishihara Color Test
NR
Gender:
G1: 15.9 ± 0.33
Ishihara Color Test
academic
attainment:
Enrollment
period:
(max = 38)
Groups:
NR
Race/ethnicity:
score, mean ± SD:
G1: 36.7 ± 1.04
Percentage
improvement
NR
Funding:
G1: Autistic children
Ga: colored overlay,
NR
SES:
reading with
colored overlays,
NR
Author industry
relationship
chosen for clarity
Gb: no colored overlay
Provider:
Maternal education: NR
Household income: NR
Diagnostic approach:
n (%):
Less than 5%:
G1: 4 (21)
disclosures:
NR
NR
Measure of treatment
Referral
Diagnostic tool/method:
5-10%:
G1: 3 (16)
Design:
Prospective case
fidelity reported:
NR
NR
Diagnostic category, n
11-20%:
G1: 6 (31)
series
Co-interventions held (%):
21-30%:
stable during treatment: Autism: 19 (100)
G1: 0
Yes
Other characteristics:
31-40%:
Concomitant therapies: NR
G1: 4 (21)
NR
41-50%:
N at enrollment:
G1: 2 (10)
G1: 19
Harms:
N at follow-up:
NR
G1: 19
Comments: *Data only illustrated graphically.
Modifiers:
The correlation
between verbal IQ
measured via
BPVS and degree
of improvement
using overlay was
not significant
C-286